BRPI0809282B8 - material granular, material de partida para uma forma de dosagem, forma de dosagem, processo de compressão direta para preparar uma forma de dosagem, uso do material granular e processo para granular um pó de polímero - Google Patents

material granular, material de partida para uma forma de dosagem, forma de dosagem, processo de compressão direta para preparar uma forma de dosagem, uso do material granular e processo para granular um pó de polímero

Info

Publication number
BRPI0809282B8
BRPI0809282B8 BRPI0809282A BRPI0809282A BRPI0809282B8 BR PI0809282 B8 BRPI0809282 B8 BR PI0809282B8 BR PI0809282 A BRPI0809282 A BR PI0809282A BR PI0809282 A BRPI0809282 A BR PI0809282A BR PI0809282 B8 BRPI0809282 B8 BR PI0809282B8
Authority
BR
Brazil
Prior art keywords
dosage form
granular material
granulate
prepare
polymer powder
Prior art date
Application number
BRPI0809282A
Other languages
English (en)
Inventor
Bellare Akshay
Chun A Chan Ka
B Ender Kacee
V Jacob Karl
E Scheid Robert
D Cabelka Tim
P Dasbach Tina
Original Assignee
Dow Global Technologies Inc
Dow Global Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc, Dow Global Technologies Llc filed Critical Dow Global Technologies Inc
Publication of BRPI0809282A2 publication Critical patent/BRPI0809282A2/pt
Publication of BRPI0809282B1 publication Critical patent/BRPI0809282B1/pt
Publication of BRPI0809282B8 publication Critical patent/BRPI0809282B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

material granular, material de partida para uma forma de dosagem, forma de dosagem, processo de compressão direta para preparar uma forma de dosagem, uso do material granular e processo para granular um pó de polímero. um material granular que tem um tamanho médio de partícula de 150 a 800 micrometros, uma densidade aparente não-sedimentada de o, 1 a o, 35 g/crn 3 e/ou uma compactabilidade que resulta num compacto com um limite de resistência à tração de pelo menos 1, 7 mpa quando submetido a urna pressão de compactação de 266 mp a; e sendo que o componente principal do material granular é um derivado de celulose, um homopolímero ou copolímero de óxido de alquileno ou urna mistura dos mesmos é útil para preparar formas de dosagem com um perfil de libe controlada .
BRPI0809282A 2007-04-13 2008-02-28 material granular, material de partida para uma forma de dosagem, forma de dosagem, processo de compressão direta para preparar uma forma de dosagem, uso do material granular e processo para granular um pó de polímero BRPI0809282B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92344607P 2007-04-13 2007-04-13
US60/923,446 2007-04-13
PCT/US2008/055274 WO2008127794A2 (en) 2007-04-13 2008-02-28 Granular material for dosage forms

Publications (3)

Publication Number Publication Date
BRPI0809282A2 BRPI0809282A2 (pt) 2014-09-02
BRPI0809282B1 BRPI0809282B1 (pt) 2019-12-24
BRPI0809282B8 true BRPI0809282B8 (pt) 2021-05-25

Family

ID=39745025

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0809282A BRPI0809282B8 (pt) 2007-04-13 2008-02-28 material granular, material de partida para uma forma de dosagem, forma de dosagem, processo de compressão direta para preparar uma forma de dosagem, uso do material granular e processo para granular um pó de polímero

Country Status (6)

Country Link
US (2) US8877249B2 (pt)
EP (1) EP2146696B1 (pt)
JP (1) JP5612462B2 (pt)
CN (1) CN101657186B (pt)
BR (1) BRPI0809282B8 (pt)
WO (1) WO2008127794A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149863A (en) 2006-08-03 2013-10-31 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
AU2010207740B2 (en) * 2009-01-26 2016-06-16 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
DE102010003204A1 (de) * 2010-03-24 2011-12-15 Evonik Degussa Gmbh Grobteilige Trägerkieselsäuren
EP2598121B1 (en) * 2010-07-28 2018-08-08 Dow Global Technologies LLC A method of controlling the release of an active ingredient from a dosage form
KR20140006964A (ko) * 2011-02-24 2014-01-16 다우 글로벌 테크놀로지스 엘엘씨 글루텐-미함유 곡분을 포함하는 조성물
BR112013023380B1 (pt) 2011-04-06 2021-03-23 Dow Global Technologies Llc Processo para produzir um derivado de celulose particulado
MX337827B (es) 2011-04-06 2016-03-22 Dow Global Technologies Llc Novedosos derivados polisacaridos y formas de administracion.
US20130149383A1 (en) * 2011-12-12 2013-06-13 Cory Berkland Sustained release particle formulations of guaifenesin
KR101936563B1 (ko) * 2012-02-10 2019-01-10 다우 글로벌 테크놀로지스 엘엘씨 특정 중간 입자 길이의 셀룰로스 유도체를 포함하는 압출성형 세라믹체를 위한 조성물
US8431155B1 (en) 2012-04-30 2013-04-30 Veroscience Llc Bromocriptine formulations
DE102012211121A1 (de) * 2012-06-28 2014-01-02 Evonik Industries Ag Granuläre, funktionalisierte Kieselsäure, Verfahren zu deren Herstellung und deren Verwendung
KR102519850B1 (ko) 2016-10-07 2023-04-10 신에쓰 가가꾸 고교 가부시끼가이샤 히드록시알킬 알킬 셀룰로오스 및 그의 제조 방법, 및 고형 제제
KR102519854B1 (ko) 2016-10-07 2023-04-10 신에쓰 가가꾸 고교 가부시끼가이샤 히드록시알킬 알킬 셀룰로오스 및 그의 제조 방법, 및 고형 제제
CN112569249A (zh) * 2020-12-29 2021-03-30 中科健康产业集团股份有限公司 一种具有抗衰老作用的番茄红素组合物的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU508480B2 (en) 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
US4734285A (en) 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US5126145A (en) * 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament
US5273758A (en) 1991-03-18 1993-12-28 Sandoz Ltd. Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
US5237758A (en) 1992-04-07 1993-08-24 Zachman Harry L Safety shoe sole construction
EP0835881B2 (de) 1996-10-14 2004-12-29 Wolff Walsrode Ag Verfahren zur Herstellung von Methylcellulose-Pulvern mit spezieller Sieblinie
DE19725911A1 (de) * 1997-06-13 1998-12-17 Roland Prof Dr Bodmeier Zusammensetzungen, die die Wirkstofffreisetzung verzögern
JP2000063565A (ja) 1998-08-20 2000-02-29 Shin Etsu Chem Co Ltd 粒状水溶性セルロースエーテル及びその製造方法
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
US6858725B1 (en) * 1999-11-12 2005-02-22 R.P. Scherer Technologies, Inc. Microcrystalline cellulose cushioning granules
AU778321B2 (en) * 1999-11-24 2004-11-25 Taisho Pharmaceutical Co., Ltd. Preparation for nasal administration
US6761905B2 (en) * 2001-05-01 2004-07-13 Wei Ming Pharmaceutical Mfg. Co., Ltd. Process for the preparation of direct tabletting formulations and aids
JP2004315713A (ja) 2003-04-18 2004-11-11 Shin Etsu Chem Co Ltd 非イオン性セルロースエーテルの製造方法及びこれにより得られる非イオン性セルロースエーテル造粒物

Also Published As

Publication number Publication date
EP2146696A2 (en) 2010-01-27
CN101657186B (zh) 2012-07-18
JP2010523688A (ja) 2010-07-15
BRPI0809282B1 (pt) 2019-12-24
BRPI0809282A2 (pt) 2014-09-02
WO2008127794A2 (en) 2008-10-23
EP2146696B1 (en) 2020-01-22
JP5612462B2 (ja) 2014-10-22
WO2008127794A3 (en) 2009-06-04
CN101657186A (zh) 2010-02-24
US8877249B2 (en) 2014-11-04
US9655851B2 (en) 2017-05-23
US20100151038A1 (en) 2010-06-17
US20140308356A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
BRPI0809282B8 (pt) material granular, material de partida para uma forma de dosagem, forma de dosagem, processo de compressão direta para preparar uma forma de dosagem, uso do material granular e processo para granular um pó de polímero
Valles et al. The effect of flake diameter on the reinforcement of few-layer graphene–PMMA composites
BRPI0514167A (pt) preparação de microcápsulas grosseiramente dividida, processo para produzir a mesma, e, uso da preparação de microcápsulas grosseiramente dividida
BR112015031906A2 (pt) material de eletrodo e uso do mesmo em baterias de íon de lítio
NZ595557A (en) Novel composite materials comprising a thermoplastic matrix polymer and wood particles
BR112016006789A2 (pt) composição acrílica endurecível de múltiplas partes, uso de uma primeira parte sólida de polímero acrílico, e, métodos para produzir um cimento acrílico e para produzir uma composição acrílica endurecível de múltiplas partes
Nouri-Niyaraki et al. Experimental analysis of graphene nanoparticles and glass fibers effect on mechanical and thermal properties of polypropylene/EPDM based nanocomposites
SG171647A1 (en) Ceramic powder and use thereof
Ren et al. Effects of carbon nanofibers on crystalline structures and properties of ultrahigh molecular weight polyethylene blend fabricated using twin‐screw extrusion
JP2022512801A (ja) 建築部材の通路開口部および接合部をシールするための複合材料および防火要素
Faisal et al. Flexural toughness of ring-shaped waste bottle fiber concrete
Qiu et al. Impact-protective bicontinuous hydrogel/ultrahigh-molecular weight polyethylene fabric composite with multiscale energy dissipation structures for soft body armor
BR112023017427A2 (pt) Cimento hidráulico à base de silicato de cálcio para formar um material compósito tendo propriedades de reforço
Rajkumar et al. Tribomechanical and surface topographical investigations of poly methyl methacrylate-seashell particle based biocomposite
FENG et al. Experimental study on mechanical property of rubber concrete
Slonov et al. Investigation of the Influence of Fillers of Various Nature on the Properties of Polyether Sulfone and Determination of the Possibility of Using Composites on their Basis in 3D-Printing
Ghezzo et al. On the damping properties of a polyurea elastomer
JP2016215196A (ja) 成形体および成形体の製造方法
Zinzuwadia et al. Fracture Toughness of Carbon Nanotube—Alumina Composite
Żenkiewicz et al. Processing and mechanical properties of poly (e-caprolactone)/graphite composites
Ohta et al. Mechanical properties of injection-moulded jute/glass fibre hybrid composites
Kumar et al. Experimental investigation on mechanical and thermo-mechanical properties of alumina filled polypropylene composites using injection molding process
Al-Rawi Wear and mechanical prop erties of epoxy/MgO-SiO2 hybrid nanocomposites
Hajizadeh et al. Effect of rubber modification on the morphology and properties of novolac nanostructures
Biswas et al. EFFECT OF ALUMINA PARTICULATE ON EROSION WEAR BEHAVIOUR OF SHORT BAMBOO FIBER REINFORCED EPOXY COMPONENTS

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/12/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/02/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved

Owner name: DOW GLOBAL TECHNOLOGIES LLC (US)

B25A Requested transfer of rights approved

Owner name: THE DOW CHEMICAL COMPANY (US)

B25A Requested transfer of rights approved

Owner name: DDP SPECIALTY ELECTRONIC MATERIALS US, INC. (US)

B25D Requested change of name of applicant approved

Owner name: DDP SPECIALTY ELECTRONIC MATERIALS US, LLC (US)

B25A Requested transfer of rights approved

Owner name: NUTRITION AND BIOSCIENCES USA 1, LLC (US)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2711 DE 20-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.